Table 2 Antimalarial treatments for children with uncomplicated malaria presenting to all health facilities – change of practice between 2004 and 2006 surveys in four districts in Zambia
2004 | 5–9 kg (N = 527) | ≥ 10 kg (N = 394) | ||
|---|---|---|---|---|
No (%) | 95% CI* | No (%) | 95% CI* | |
Artemether-lumefantrine | 6 (1.1) | 0, 2.7 | 42 (10.7) | 5.4, 16.0 |
Sulphadoxine-pyrimethamine | 422 (80.1) | 73.9, 86.2 | 266 (67.5) | 58.8, 76.2 |
Quinine | 14 (2.7) | 0.8, 4.5 | 19 (4.8) | 2.0, 7.6 |
Chloroquine | 1 (0.2) | 0, 0.6 | 0 | NA |
No antimalarial prescribed | 84 (15.9) | 10.3, 21.6 | 67 (17.0) | 11.7, 22.3 |
2006 | 5–9 kg (N = 552) | ≥ 10 kg (N = 547) | ||
No (%) | 95% CI* | No (%) | 95% CI* | |
Artemether-lumefantrine | 149 (27.0) | 19.2, 34.8 | 231 (42.2) | 33.8, 50.7 |
Sulphadoxine-pyrimethamine | 214 (38.8) | 30.9, 46.7 | 151 (27.6) | 19.9, 35.3 |
Quinine | 26 (4.7) | 1.5, 7.9 | 38 (7.0) | 2.5, 11.4 |
No antimalarial prescribed | 163 (29.5) | 23.3, 35.8 | 127 (23.2) | 17.9, 28.5 |